Inovio Pharmaceuticals, Inc.
INO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001055726
No open-market purchases or sales by Inovio Pharmaceuticals, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $36.1M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Inovio Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 201 | 3 | 185 | −13 |
| Shares | 92.0M | 148.1K | 113.4M | +21.5M (+23.4%) |
| Value | $330.4M | $531.0K | $196.2M | −$133.7M (−40.5%) |
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 85,504 | $148.0K | 0.01% |
| Balyasny Asset Management LLC | 56,484 | $98.0K | 0.00% |
| Squarepoint Ops LLC | 48,608 | $84.0K | 0.00% |
| XR Securities LLC | 40,178 | $70.0K | 0.03% |
| Keebeck Alpha, LP | 16,756 | $29.0K | 0.01% |
| Diametric Capital, LP | 15,440 | $27.0K | 0.02% |
| Tiaa, FSB | 14,348 | $25.0K | 0.00% |
| Xponance, Inc. | 11,866 | $21.0K | 0.00% |
| Private Advisor Group, LLC | 10,213 | $18.0K | 0.00% |
| Kestra Advisory Services, LLC | 10,427 | $18.0K | 0.00% |
| TCI Wealth Advisors, Inc. | 1,682 | $3.00K | 0.00% |
| Covington Capital Management | 1,000 | $2.00K | 0.00% |
| Bell Investment Advisors, Inc | 438 | $1.00K | 0.00% |
| Brown, Lisle/Cummings, Inc. | 7 | $12 | 0.00% |
| Brown Brothers Harriman & Co | 33 | $0 | 0.00% |
| Huntington National Bank | 400 | $0 | 0.00% |
| Harbour Investments, Inc. | 192 | $0 | 0.00% |
| McMillion Capital Management Inc | 145 | $0 | 0.00% |
| Ellevest, Inc. | 72 | $0 | 0.00% |
| Urban Wealth Management, LLC | 200 | $0 | 0.00% |
| CoreCap Advisors, LLC | 200 | $0 | 0.00% |
Sold out (34)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (3)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 123,167 | $442.0K |
| Amalgamated Financial Corp. | 24,893 | $89.0K |
| SJS Investment Consulting Inc. | 7 | $0 |